PAVmed (PAVM) Cash from Financing Activities (2015 - 2025)

PAVmed's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at -$2000.0 for Q3 2025.

• In Q3 2025, Cash from Financing Activities changed N/A year-over-year to -$2000.0; the TTM figure through Dec 2025 stood at $5.6 million (down 84.6% YoY), while the FY2025 annual figure was $5.6 million, down 82.13% from the prior year.
• Cash from Financing Activities was -$2000.0 for Q3 2025 at PAVmed, down from $2.5 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $60.1 million in Q4 2021 to a low of -$2000.0 in Q3 2025.
• Historically, Cash from Financing Activities has averaged $11.7 million across 5 years, with a median of $2.8 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 99.87% in 2022, then soared 7787.34% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at $60.1 million in 2021, then slumped by 99.87% to $80000.0 in 2022, then surged by 6510.0% to $5.3 million in 2023, then tumbled by 93.76% to $330000.0 in 2024, then plunged by 100.61% to -$2000.0 in 2025.
• The last three Cash from Financing Activities figures came in at -$2000.0 (Q3 2025), $2.5 million (Q2 2025), and $3.1 million (Q1 2025), per Business Quant data.